How is urinary hippurate measured and interpreted, and what clinical conditions are associated with low or high levels?

Urinary Hippurate Measurement and Clinical Interpretation

Urinary hippurate is measured using colorimetric assays or mass spectrometry in spot urine samples normalized to creatinine, with reference values typically ranging from 0.15-0.38 g/g creatinine, and serves as a biomarker for gut microbiota metabolism, dietary intake (particularly fruits and vegetables), metabolic health, and toxic exposures.

Measurement Methods

Laboratory Techniques

• Colorimetric assays: Using p-toluenesulfonyl chloride (p-TsCl) can detect hippuric acid from 60 μM to 1000 μM in urine within 2 minutes 1
• Mass spectrometry: More sensitive than traditional methods, with lower reference limits 2
• Supramolecular sensing: Novel fluorescence-based methods can quantify urinary hippuric acid in the range of 0.10-10.93 mM 3

Sample Collection and Handling

• Use spot urine samples (morning or random) normalized to creatinine—24-hour collections are unnecessary 4
• Results should be expressed as g hippuric acid/g creatinine or mol/mmol creatinine
• Interpret cautiously when urinary creatinine is below 2 mmol/L, as results may appear falsely elevated 2

Reference Values

Normal urinary hippuric acid levels 5:

• Mean ± SD: 0.18 ± 0.10 g/g creatinine
• Median: 0.15 g/g creatinine
• 95th percentile: 0.36 g/g creatinine
• Upper reference value: 0.38 g/g creatinine

Factors Affecting Reference Values

• Age and gender significantly affect levels (women and different age groups show statistically significant differences) 5
• Alcohol consumption and smoking do not significantly impact results 5

Clinical Conditions Associated with Altered Hippurate Levels

Low Hippuric Acid Levels (<0.76 mM)

Metabolic disorders show a significantly negative correlation with urinary hippuric acid when levels fall below 0.76 mM 3. Low levels are associated with:

• Metabolic syndrome and related disorders: Obesity, diabetes 6
• Gastrointestinal diseases: Crohn's disease, altered gut microbiota composition 1, 6
• Chronic kidney disease: Impaired renal function 1, 6
• Psychological disorders: Schizophrenia, autism 6
• Poor dietary habits: Low consumption of fruits, vegetables, coffee, and tea 3

High Hippuric Acid Levels

Elevated urinary hippurate indicates:

• Toxic exposures:

  • Toluene exposure (occupational biomarker) 5, 7
  • Aromatic compound exposure 1
  • Xylene exposure causes elevation of 2-methylhippurate specifically 7

• Dietary factors: High consumption of fruits, vegetables, coffee, and tea rich in benzoic acid precursors 3, 6

• Enhanced hepatic detoxification: Increased conjugation capacity 6

Critical Analytical Interferences

Important Caveats

Methenamine hippurate (used for UTI prophylaxis) causes false positives in colorimetric PBG assays for porphyria diagnosis 2. This is a critical pitfall when:

• Evaluating patients on methenamine hippurate for suspected acute porphyria
• Using colorimetric methods for porphobilinogen (PBG) measurement
• The drug can cause false-negative results in these assays 2

Other Analytical Considerations

• Penicillin and tienam can also cause false positives in colorimetric methods 2
• Very dilute urine may lead to misleading results if not normalized to creatinine 4
• Mass spectrometry methods are more sensitive and have lower reference limits than traditional ion-exchange methods 2

Clinical Algorithm for Interpretation

1. Verify sample quality: Check urinary creatinine >2 mmol/L
2. Normalize results: Express as ratio to creatinine
3. Consider medication history: Specifically methenamine hippurate, antibiotics
4. Assess dietary intake: Recent consumption of fruits, vegetables, coffee, tea
5. Evaluate for metabolic risk: Levels <0.76 mM suggest increased metabolic disorder risk 3
6. Screen for toxic exposure: Elevated levels with occupational history warrant investigation
7. Correlate with clinical context: Gut health, renal function, metabolic parameters

When hippurate levels are low (<0.76 mM), recommend dietary intervention emphasizing fruits, vegetables, coffee, and tea to reduce metabolic disorder risk 3.